Incongruence between confirmed and suspected clinical cases of Japanese encephalitis virus infection.

Epstein-Barr virus Japanese encephalitis Japanese encephalitis virus enterovirus unknown viral encephalitis viral encephalitis viral encephalitis in adults

Journal

Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359

Informations de publication

Date de publication:
2024
Historique:
received: 26 09 2023
accepted: 09 01 2024
medline: 12 2 2024
pubmed: 12 2 2024
entrez: 12 2 2024
Statut: epublish

Résumé

Japanese encephalitis (JE) is a notifiable infectious disease in China. Information on every case of JE is reported to the superior health administration department. However, reported cases include both laboratory-confirmed and clinically diagnosed cases. This study aimed to differentiate between clinical and laboratory-confirmed cases of Japanese encephalitis virus (JEV) infection, and improve the accuracy of reported JE cases by analyzing the acute-phase serum and cerebrospinal fluid of all reported JE cases in the Sichuan province from 2012 to 2022. All acute-phase serum and/or cerebrospinal fluid samples of the reported JE cases were screened for IgM(ImmunoglobulinM)to JEV using the enzyme-linked immunosorbent assay (ELISA), and the detection of the viral genes of JEV and 9 other pathogens including enterovirus (EV), using reverse transcription PCR was attempted. Epidemiological analyses of JE and non-JE cases based on sex, age, onset time, and geographical distribution were also performed. From 2012 to 2022, 1558 JE cases were reported in the Sichuan province. The results of serological (JEV-specific IgM) and genetic testing for JEV showed that 81% (1262/1558) of the reported cases were confirmed as JEV infection cases (laboratory-confirmed cases). Among the 296 cases of non-JEV infection, 6 viruses were detected in the cerebrospinal fluid in 62 cases, including EV and the Epstein-Barr virus (EBV), constituting 21% (62/296) of all non-JE cases. Among the 62 non-JEV infection cases with confirmed pathogens, infections with EV and EBV included 17 cases each, herpes simplex virus (HSV-1/2) included 14 cases, varicella- zoster virus included 6 cases, mumps virus included 2 cases, and human herpes viruses-6 included 1 case. Additionally, there were five cases involving mixed infections (two cases of EV/EBV, one case of HSV-1/HSV-2, one case of EBV/HSV-1, and one case of EV/herpes viruses-6). The remaining 234 cases were classified as unknown viral encephalitis cases. Our analysis indicated that those aged 0-15 y were the majority of the patients among the 1558 reported JE cases. However, the incidence of laboratory-confirmed JE cases in the >40 y age group has increased in recent years. The temporal distribution of laboratory-confirmed cases of JE revealed that the majority of cases occurred from May to September each year, with the highest incidence in August. The results of this study indicate that there is a certain discrepancy between clinically diagnosed and laboratory-confirmed cases of JE. Each reported case should be based on laboratory detection results, which is of great importance in improving the accuracy of case diagnosis and reducing misreporting. Our results are not only important for addressing JE endemic to the Sichuan province, but also provide a valuable reference for the laboratory detection of various notifiable infectious diseases in China and other regions outside China.

Sections du résumé

Background UNASSIGNED
Japanese encephalitis (JE) is a notifiable infectious disease in China. Information on every case of JE is reported to the superior health administration department. However, reported cases include both laboratory-confirmed and clinically diagnosed cases. This study aimed to differentiate between clinical and laboratory-confirmed cases of Japanese encephalitis virus (JEV) infection, and improve the accuracy of reported JE cases by analyzing the acute-phase serum and cerebrospinal fluid of all reported JE cases in the Sichuan province from 2012 to 2022.
Methods UNASSIGNED
All acute-phase serum and/or cerebrospinal fluid samples of the reported JE cases were screened for IgM(ImmunoglobulinM)to JEV using the enzyme-linked immunosorbent assay (ELISA), and the detection of the viral genes of JEV and 9 other pathogens including enterovirus (EV), using reverse transcription PCR was attempted. Epidemiological analyses of JE and non-JE cases based on sex, age, onset time, and geographical distribution were also performed.
Results UNASSIGNED
From 2012 to 2022, 1558 JE cases were reported in the Sichuan province. The results of serological (JEV-specific IgM) and genetic testing for JEV showed that 81% (1262/1558) of the reported cases were confirmed as JEV infection cases (laboratory-confirmed cases). Among the 296 cases of non-JEV infection, 6 viruses were detected in the cerebrospinal fluid in 62 cases, including EV and the Epstein-Barr virus (EBV), constituting 21% (62/296) of all non-JE cases. Among the 62 non-JEV infection cases with confirmed pathogens, infections with EV and EBV included 17 cases each, herpes simplex virus (HSV-1/2) included 14 cases, varicella- zoster virus included 6 cases, mumps virus included 2 cases, and human herpes viruses-6 included 1 case. Additionally, there were five cases involving mixed infections (two cases of EV/EBV, one case of HSV-1/HSV-2, one case of EBV/HSV-1, and one case of EV/herpes viruses-6). The remaining 234 cases were classified as unknown viral encephalitis cases. Our analysis indicated that those aged 0-15 y were the majority of the patients among the 1558 reported JE cases. However, the incidence of laboratory-confirmed JE cases in the >40 y age group has increased in recent years. The temporal distribution of laboratory-confirmed cases of JE revealed that the majority of cases occurred from May to September each year, with the highest incidence in August.
Conclusion UNASSIGNED
The results of this study indicate that there is a certain discrepancy between clinically diagnosed and laboratory-confirmed cases of JE. Each reported case should be based on laboratory detection results, which is of great importance in improving the accuracy of case diagnosis and reducing misreporting. Our results are not only important for addressing JE endemic to the Sichuan province, but also provide a valuable reference for the laboratory detection of various notifiable infectious diseases in China and other regions outside China.

Identifiants

pubmed: 38343888
doi: 10.3389/fcimb.2024.1302314
pmc: PMC10853334
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1302314

Informations de copyright

Copyright © 2024 Li, Feng, Zhong, Jiang, Zhang, Lin, Chen, He, Zhang, Fu, Wang and Liang.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

PLoS Negl Trop Dis. 2013 Jun 20;7(6):e2285
pubmed: 23819000
Transbound Emerg Dis. 2021 Nov;68(6):3415-3423
pubmed: 33283432
Vector Borne Zoonotic Dis. 2019 Jan;19(1):26-34
pubmed: 29741995
Curr Opin Virol. 2015 Apr;11:44-54
pubmed: 25681709
Euro Surveill. 2012 Jul 12;17(28):
pubmed: 22835438
PLoS Negl Trop Dis. 2020 May 26;14(5):e0008312
pubmed: 32453787
Am J Trop Med Hyg. 2010 Oct;83(4):766-73
pubmed: 20889863
J Clin Microbiol. 2010 Apr;48(4):1343-9
pubmed: 20147638
Euro Surveill. 2012 Aug 09;17(32):
pubmed: 22913940
Emerg Infect Dis. 2020 May;26(5):1002-1006
pubmed: 32310056
PLoS Negl Trop Dis. 2014 Aug 14;8(8):e3015
pubmed: 25121596
Infect Drug Resist. 2022 Oct 18;15:6009-6017
pubmed: 36267265
PLoS Negl Trop Dis. 2016 May 03;10(5):e0004686
pubmed: 27139722
J Virol. 2011 Oct;85(19):9847-53
pubmed: 21697481
Front Neurol. 2019 Aug 22;10:918
pubmed: 31507521
Biomed Environ Sci. 2021 Mar 20;34(3):175-183
pubmed: 33766213
PLoS One. 2014 Jun 09;9(6):e99183
pubmed: 24911168
PLoS Negl Trop Dis. 2016 Apr 06;10(4):e0004611
pubmed: 27050414
Bull World Health Organ. 2011 Oct 1;89(10):766-74, 774A-774E
pubmed: 22084515
Emerg Infect Dis. 2013 Apr;19(4):672-3
pubmed: 23750863
Rev Med Virol. 2012 Sep;22(5):301-22
pubmed: 22407526
Emerg Infect Dis. 2007 Jul;13(7):1123-5
pubmed: 18214202
Handb Clin Neurol. 2014;123:561-76
pubmed: 25015504
N Engl J Med. 2017 Apr 13;376(15):1483-1485
pubmed: 28402771
Zhonghua Yi Xue Za Zhi. 2023 Mar 7;103(9):648-657
pubmed: 36858364
N Engl J Med. 2006 Aug 31;355(9):869-71
pubmed: 16943399

Auteurs

Wei Li (W)

Institute of Microbiological Detection and Analyses, Sichuan Center for Disease Control and Prevention, Chengdu, China.

Yuliang Feng (Y)

Institute of Microbiological Detection and Analyses, Sichuan Center for Disease Control and Prevention, Chengdu, China.

Hongrong Zhong (H)

Institute of Microbiological Detection and Analyses, Sichuan Center for Disease Control and Prevention, Chengdu, China.

Mingfeng Jiang (M)

Institute of Microbiological Detection and Analyses, Sichuan Center for Disease Control and Prevention, Chengdu, China.

Jiake Zhang (J)

Institute of Microbiological Detection and Analyses, Sichuan Center for Disease Control and Prevention, Chengdu, China.

Shihua Lin (S)

Institute of Microbiological Detection and Analyses, Sichuan Center for Disease Control and Prevention, Chengdu, China.

Na Chen (N)

Institute of Microbiological Detection and Analyses, Sichuan Center for Disease Control and Prevention, Chengdu, China.

Shusen He (S)

Institute of Microbiological Detection and Analyses, Sichuan Center for Disease Control and Prevention, Chengdu, China.

Kai Zhang (K)

Institute of Immunization Programme, Sichuan Center for Disease Control and Prevention, Chengdu, China.

Shihong Fu (S)

Department of Arbovirus, National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

Huanyu Wang (H)

Department of Arbovirus, National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

Guodong Liang (G)

Department of Arbovirus, National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

Classifications MeSH